Clinical Practice Guideline
Mechanical Ventilation and Extracorporeal Membrane Oxygenation in Acute Respiratory Insufficiency
; ; ; ; ;
Background: Mechanical ventilation is life-saving for patients with acute respiratory insufficiency. In a German prevalence study, 13.6% of patients in intensive care units received mechanical ventilation for more than 12 hours; 20% of these patients received mechanical ventilation as treatment for acute respiratory distress syndrome (ARDS). The new S3 guideline is the first to contain recommendations for the entire process of treatment in these groups of patients (indications, ventilation modes/parameters, accompanying measures, treatments for refractory impairment of gas exchange, weaning, and follow-up care).
Methods: This guideline was developed according to the GRADE methods. Pertinent publications were identified by a systematic search of the literature, the quality of the evidence was evaluated, a risk/benefit assessment was conducted, and recommendations were issued by interdisciplinary consensus.
Results: Mechanical ventilation is recommended as primary treatment for patients with severe ARDS. In other patient groups, non-invasive ventilation can lower mortality. If mechanical ventilation is needed, ventilation modes allowing spontaneous breathing seem beneficial (quality of evidence [QoE]: very low). Protective ventilation (high positive end-expiratory pressure, low tidal volume, limited peak pressure) improve the survival of ARDS patients (QoE: high). If a severe impairment of gas exchange is present, prone positioning lessens mortality (QoE: high). Veno-venous extracorporeal membrane oxygenation (vvECMO) has not unequivocally been shown to improve survival. Early mobilization and weaning protocols can shorten the duration of ventilation (QoE: moderate).
Conclusion: Recommendations for patients undergoing mechanical ventilation include lung-protective ventilation, early spontaneous breathing and mobilization, weaning protocols, and, for those with severe impairment of gas exchange, prone positioning. It is further recommended that patients with ARDS and refractory impairment of gas exchange should be transferred to an ARDS/ECMO center, where extracorporeal methods should be applied only after application of all other therapeutic options.
Mechanical ventilation through an endotracheal tube or tracheostomy is an essential treatment for patients with acute respiratory insufficiency of any cause and is one of the major types of apparatus-assisted treatment in intensive care units. In a German prevalence study, 13.6% of patients in intensive care units received mechanical ventilation for more than 12 hours; 20% of these patients received mechanical ventilation as treatment for acute respiratory distress syndrome (ARDS) (1).
Although many clinical trials of mechanical ventilation have been conducted, there has not yet been any comprehensive clinical practice guideline based on a systematic review and assessment of the pertinent literature.
Mechanically ventilated patients now receive care of variable quality. For example, simple measures that improve survival, such as limiting the tidal volume and peak inspiratory pressure, are clinically implemented in only approximately two-thirds of patients with ARDS (2). At the same time, extracorporeal gas-exchange methods have become easier to use through technical improvements and are now being used more commonly and sometimes indiscriminately, in the absence of adequate scientific evidence for the specific clinical use (3).
The new S3 guideline is a source of evidence-based information and an aid to clinical decision-making on mechanical ventilation and extracorporeal techniques in patients with acute respiratory insufficiency. The text of the guideline is practically organized, along the lines of the course of treatment of such patients in the intensive care unit: the indications for mechanical ventilation and the alternatives to it (if applicable) are discussed first, followed by the choice of a ventilation mode, the setting of ventilation parameters, accompanying measures, the treatment of refractory impairment of gas exchange, weaning off the ventilator, and follow-up care after mechanical ventilation has been discontinued.
The present article summarizes the new S3 guideline and contains its key recommendations. The complete guideline is available for no charge on the web portal of the Association of the Scientific Medical Societies in Germany (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften, AWMF) (www.awmf.org/leitlinien/detail/ll/001–021.html).
The guideline group, which received methodological support from the AWMF, comprised 59 delegates of 21 scientific medical societies from Germany, Austria, and Switzerland, representing all of the medical disciplines and professions that make up the treatment team in an intensive care unit; patient representatives were included as well (eBox). Over the four-year period of guideline development, all group members provided statements of their conflicts of interest, which were then evaluated. Members with relevant conflicts of interest abstained from voting on the corresponding recommendations. The conflicts of interest are described in detail in the guideline report.
The guideline was developed according to the GRADE methods (Grading of Recommendations, Assessment, Development and Evaluation) (4).
The systematic literature search was carried out in PubMed, Embase, Cochrane, and international guideline databases (publication dates: any time up to December 2014 for the main search, any time up to June 2016 for the search update [only meta-analyses and randomized, controlled trials]).
Publications were selected by topic according to uniform criteria, the selected studies were sorted by type, and a full-text database encompassing approximately 3500 studies was created (as per the PRISMA scheme, cf. eFigure).
In the literature assessment, national and international guidelines were examined, and relevant content of high-quality guidelines was adopted. Next, current meta-analyses were analyzed and evaluated. In the absence of evaluable meta-analyses, randomized and controlled trials (RCT) and studies that provided evidence of lesser quality were analyzed, evaluated, and summarized in evidence tables. Finally, the literature on each question was summarized using evidence profiles and then qualitatively assessed (for the five categories of quality of evidence [QoE], see eTable 1) (5).
The recommendations found in the guideline are thus based on information from a total of 297 evaluated publications.
On the basis of this evidence, the benefits and risks of each therapeutic measure were evaluated and the content and strength of the relevant recommendations were categorized into 3 strengths of evidence (eTable 1) (6). Clinical experience, patient preferences, and an estimate of the necessary resources were also taken into account. The strength of each recommendation therefore does not always directly reflect the previously determined quality of the underlying evidence.
The recommendations were voted on within the guideline group individually and in a two-step process by each participating scientific medical society.
In the following paragraphs we present key recommendations that the guideline group considers especially important in terms of achieving a clinical benefit for patients, or avoiding harm to them. We also present recommendations that deviate from the current clinical practice or that address topics that remain controversial.
The definition of acute respiratory insufficiency
Acute respiratory insufficiency has no uniform definition. In awake patients, its leading symptom is dyspnea; impaired consciousness is a further important clinical sign. Blood-gas analysis enables the differentiation of hypoxemia, hypercapnia, and mixed forms, but uniform threshold values and definitions are lacking.
In routine clinical practice, patients are mechanically ventilated when the treating team judges that acute hypoxemic/hypercapnic respiratory insufficiency is present. It is, therefore, suggested that the guideline should be applied, independently of the imprecise definition of acute respiratory insufficiency, whenever the treating team considers a patient to need mechanical ventilation or is contemplating the initiation of an extracorporeal technique.
For the disease entity ARDS, the present guideline follows the Berlin definition (eTable 2) (7).
Indications for mechanical ventilation
It is recommended that patients with severe ARDS should be treated primarily with invasive mechanical ventilation (expert consensus, weak recommendation). For patients with ARDS, benefits of non-invasive ventilation have not been definitively demonstrated, but harm may be potentially induced (delayed emergency intubation with the risk of hypoxemia).
A trial of non-invasive ventilation is, however, recommended for all other groups of patients with acute respiratory insufficiency (QoE + to ++++; strong/weak recommendations).
In palliative care, the alleviation of dyspnea is a central objective (8). It is recommended that the treating team should ascertain early in the patient’s course whether non-invasive or invasive mechanical ventilation would be consistent with the patient’s wishes (expert consensus, strong recommendation).
The choice of ventilation mode
Many different ventilation modes are available (Table), but only a few of them are regularly used in clinical practice. In controlled ventilation, a ventilator performs all of the work of breathing. In assisted ventilation, by definition, the ventilator performs only part of the work; spontaneous breathing is enabled and supported.
When choosing a ventilation mode, one must first ascertain whether spontaneous breathing can be enabled. Excessive sedation is associated with higher long-term mortality (9). In general, therefore, the target of sedation is a patient who is as awake as possible, with intact spontaneous breathing (10). It is recommended that an assisted ventilation mode be initiated early on, in order to enable spontaneous breathing (QoE +; weak recommendation).
On the other hand, for patients with severe ARDS, a single multicenter RCT showed that 28-day mortality was significantly lowered by muscle relaxation to eliminate spontaneous breathing (cis-atracurium 23.7% vs. control 33.3%) (11). This study was of limited methodological quality, however, and there are risks associated with oversedation and prolonged diaphragmatic inactivity. Therefore, no recommendation can now be given either for or against the enabling of spontaneous breathing in the first 48 hours in patients with severe ARDS (QoE ++; no recommendation grade).
Because of the low quantity and quality of the published research findings, the guideline group could not identify any particular ventilation mode that was more beneficial than others. Nonetheless, to avoid harming patients, it is recommended that high-frequency oscillation ventilation (HFOV) should not be used to treat adult patients with ARDS (QoE ++++; strong recommendation), because the most recent meta-analysis (12) showed no advantage for survival, while a recent large-scale RCT (13) showed a significant rise in in-hospital mortality among patients treated with HFOV compared to conventional protective ventilation (HFOV 47%, control 35%).
Ventilation parameter settings
Positive end-expiratory pressure (PEEP)
PEEP is intended to counteract a decline in functional residual capacity. Its potential major side effects include overexpansion of ventilated portions of the lung, diminished cardiac output, and elevated intracranial pressure.
Two meta-analyses, each of which was based on three multicenter RCTs, showed that ventilation with high PEEP lowers the mortality of ARDS patients, compared to ventilation with low PEEP or conventional ventilation (for mortality in the intensive care unit, 37.6% vs. 56.3%; for in-hospital mortality, 34.1% vs. 39.1% [14, 15]). Thus, in patients with ARDS, ventilation with high PEEP is recommended (QoE ++++; strong recommendation).
The use of ventilatory protocol cards of the ARDS Network (www.ardsnet.org/tools) to determine the PEEP setting is both very well-documented and easily implementable, but these tables take no account of individual respiratory mechanics (QoE ++; weak recommendation).
Inspiratory oxygen concentration (FiO2)
In observational studies on selected groups of patients, hyperoxia was found to be associated with increased mortality (16). At the same time, restrictive FiO2 settings in mechanically ventilated patients were not found to be associated with elevated mortality or organ failure rates (17). It is, therefore, recommended that mechanically ventilated patients should be treated with the lowest possible FiO2 with which a target arterial oxygen saturation (SaO2) of 90–94% or an arterial partial pressure of oxygen (PaO2) of 60–80 mmHg (8.0–10.7 kPa) can be attained (expert consensus, weak recommendation).
High tidal volumes (Vt) can cause additional ventilator-associated lung damage through overexpansion.
It was found in two meta-analyses (18, 19) that low tidal volumes lower the mortality of ARDS patients (reduction of in-hospital mortality from 43.2% to 34.5% ). It is, therefore, recommended that ARDS patients should be ventilated with a Vt not exceeding 6 mL/kg standard body weight (BW) (QoE +++; strong recommendation).
Likewise, for mechanically ventilated patients without ARDS, meta-analyses have shown positive effects on critical outcome variables (meta-analysis : reduction of postoperative complications from 14.7% [Vt > 8 mL/kg standard BW] to 8.7% [Vt < 8 mL/kg standard BW]).
Ventilation with low tidal volumes is, therefore, recommended for patients without ARDS (Vt in the range of 6–8 mL/kg standard BW) (QoE +++; strong recommendation).
Peak inspiratory pressure
The limitation of peak inspiratory pressure to prevent barotrauma is a component of a lung-protective ventilation strategy. In a meta-analysis (19), reduced mortality was found only in three trials in which the peak inspiratory pressure was greater than 31 cm H2O in the control group (mortality 31.9% with protective ventilation versus 42.6% in the control group). The peak inspiratory pressure for patients with ARDS should therefore not exceed 30 cm H2O (QoE +++; strong recommendation).
Sedation, analgesia, management of delirium
The recommendations of the German S3 guideline on analgesia, sedation, and delirium management in intensive-care medicine (10) were adopted. The strong recommendations for the use of the Richmond Agitation-Sedation Scale (RASS) with a target value of 0 to −1 in intensive-care patients for whom mild sedation is not contraindicated, and for individually adapted pain management, are of particular importance when a patient is being weaned off mechanical ventilation.
The recommendations of the S2e guideline on positioning therapy and early mobilization for the prevention or treatment of pulmonary dysfunction (21) were adopted, with additional consideration of more recent study findings: early mobilization (≤ 72 hours after admission to the intensive care unit) is considered to be a safe measure contributing to an improved outcome (shorter ICU and hospital stays) and is therefore strongly recommended, unless contraindicated.
In 2013, the German Commission for Hospital Hygiene and Infection Prevention (Kommission für Krankenhaushygiene und Infektionsprävention, KRINKO) recommended that alkalizing drugs to prevent stress ulcers should not be given to patients receiving enteral nutrition, and that an individual decision should be made on this matter for critically ill patients receiving parenteral nutrition (22). In a recent meta-analysis, a subgroup analysis of appropriately randomized studies revealed no relevant effects on the rates of pneumonia and clinically relevant gastrointestinal hemorrhage. It is, therefore, recommended that mechanically ventilated patients should not routinely be given H2-blockers or proton-pump inhibitors for stress-ulcer prophylaxis (QoE ++; strong recommendation).
In the absence of high-quality clinical trials, the guideline group adopted the recommendation formulated by expert consensus in multiple international guidelines (23–25) that the need for a tracheostomy should always be evaluated individually in each patient.
The timing of tracheostomy has been the subject of many randomized, controlled trials; two recent meta-analyses yielded contradictory findings (26, 27). The subgroup analysis on 1-year mortality revealed no significant effect of early tracheostomy (i.e., within one week of intubation; meta-analysis, 788 patients, early tracheostomy 49.7% versus late tracheostomy 53.4 %). Nor was there any demonstrable reduction of the rate of ventilator-associated pneumonia (27). On the other hand, the danger of unnecessary tracheostomy is well-documented (meta-analysis, 2689 patients, rate of tracheostomy actually performed: early tracheostomy group, 86.7%, versus late tracheostomy group, 53.4%) (26). These data provide the basis for a recommendation against early tracheostomy in mechanically ventilated patients (QoE +++; strong recommendation).
The treatment of severe or refractory impairment of gas exchange
In a meta-analysis on the use of recruitment maneuvers (RM), i.e., ventilation maneuvers in which the peak inspiratory pressure is raised in order to reopen atelectatic areas of the lungs, in-hospital mortality was found to be lower in the treatment group than in the control group (36% versus 32%, relative risk [RR] 0.84, 95% confidence interval [0.74; 0.95]). However, in many of the trials underlying this meta-analysis, RM was but one component of a bundle of therapeutic measures that were provided, and there was therefore a high risk of bias (28). In the trials with low bias, no mortality-lowering effect was seen. Therefore, it was decided not to make any recommendation in the present guideline either for against the performance of recruitment maneuvers in patients with ARDS, despite the presence of such a recommendation in the international sepsis guideline (29).
The recommendations of the S2e guideline on positioning therapy (21) were examined and compared with the current literature. Prone positioning, when initiated soon after the diagnosis of severe acute pulmonary failure (here: PaO2/FiO2 <150 mmHg) and continued for at least 16 hours, is associated with reduced long-term mortality (meta-analysis, 977 patients in subgroup with PaO2/FiO2 <150 mmHg: long-term mortality reduced from 54.7% to 41.5%, RR 0.77 [0.65; 0.92]) (30). The guideline group therefore adopted the strong recommendation of the S2e guideline that ARDS patients with a severely impaired oxygenation (here: PaO2/FiO2 <150 mm Hg) should be intermittently positioned prone.
Inhaled nitric oxide (iNO) therapy
A pertinent meta-analysis showed no reduction of mortality by iNO therapy in ARDS patients (31); at the same time, an elevated rate of acute renal failure was seen (meta-analysis, 919 patients in the ARDS subgroup, renal failure rates 19% in the iNO group vs. 12.4% in the control group, RR 1.55 [1.15; 2.09]) (32). The routine use of iNO therapy is, therefore, not recommended for patients with ARDS (QoE +++; strong recommendation).
Extracorporeal gas-exchange techniques
No prospective, randomized, controlled trials have yet clearly demonstrated the mortality benefit of extracorporeal gas-exchange techniques for patients with ARDS. On the basis of expert consensus, the use of veno-venous ECMO is recommended only as a rescue measure for patients with severe ARDS and refractory hypoxemia, after all other treatment options have been exhausted (expert consensus, strong recommendation).
ECMO carries a high risk of severe complications and requires a complex, multidisciplinary care structure. It is, therefore, strongly recommended that patients with severe ARDS and refractory hypoxemia should be cared for in a center where ECMO is available and is, as a rule, performed in at least 20 patients per year (expert consensus, strong recommendation).
Purely extracorporeal CO2 elimination with low-flow systems has not been shown to date to have any effect on survival or on the duration of ICU stays, but it does have a higher rate of clinically relevant complications (33, 34). In order to avoid additional harm in the absence of any demonstrated benefit, it is strongly recommended that low-flow systems for extracorporeal CO2 elimination should not be used to lessen the invasiveness of ventilation in patients with ARDS (expert consensus, strong recommendation).
Weaning off mechanical ventilation
Most patients can be rapidly weaned off mechanical ventilation, but weaning is difficult for some (24). Weaning protocols are used as an aid to the early evaluation of the patient’s ability to be weaned. The use of weaning protocols in adult patients who have been mechanically ventilated for more than 24 hours has been shown to significantly lessen the mean duration of ventilation (from 72 hours to 54 hours) and is therefore recommended for such patients (QoE +++; strong recommendation) (35).
Specific long-term sequelae
In the German S3 guideline on analgesia, sedation, and delirium management in intensive-care medicine (10), attention was drawn to post-traumatic stress disorder (PTSD) as a potential long-term sequela of treatment in an intensive care unit. This risk motivated the recommendation that patients’ families should be informed about PTSD and anxiety disorders in a documented conversation that includes structured information on how best to deal with patients requiring mechanical ventilation in an intensive care unit (expert consensus, weak recommendation).
Important clinical trials that are relevant to the topic of this guideline, but were published after the end of the guideline development process, are listed in Box 1.
The main objectives of this guideline are: (1) the improved clinical implementation of therapeutic measures that have been shown to be effective in mechanically ventilated patients, and (2) the reduction of excessive treatment with measures whose benefit has not been clearly demonstrated. In pursuit of these aims, the guideline group defined 119 recommendations, among which are 27 key recommendations, which, if consistently implemented, should improve the quality of clinical care in intensive care units.
The guideline is organized along the lines of the temporal course of an individual patient’s treatment in order to make it easier to use. To improve its rapid accessibility, multiple shortened versions (“Short Version,” “Key Recommendations and Quality Indicators,” eTables, eBox) and a “Pocket Edition” (Box 2) were also developed. The Pocket Edition reproduces the central statements of the guideline. An accompanying implementation study is now being carried out to identify and analyze any major barriers that might impede the implementation of the recommendations contained in the guideline. Based on the findings of this study, an implementation manual will be created that will make it easier for users to apply the scientific evidence on mechanical ventilation therapy in their clinical work in the intensive care unit.
Conflict of interest statement
Prof. Moerer has received lecture honoraria from Pulsion, CareFusion, and Maquet. His department has received research funding from Maquet, CareFusion, B. Braun, CSL Behring, LMA, Pulsion, and Med. Systems.
Prof. Weber-Carstens has received funding for a research project that he initiated, as well as for the performance of clinical trials, from the Dräger company (and he therefore abstained from voting on related subjects during the development of this S3 guideline).
PD Dr. Laudi, Dr. Fichtner, Dr. Nothacker, and Prof. Kaisers state that they have no conflict of interest.
Manuscript submitted on 18 June 2018, revised version accepted on
12 September 2018.
Translated from the original German by Ethan Taub, M.D.
Dr. med. Falk Fichtner
Universitätsklinikum Leipzig AöR, Klinik und Poliklinik für Anästhesiologie und
Intensivtherapie, Interdisziplinäre Operative Intensivstation
Liebigstr. 20,D-04103 Leipzig, Germany
eBoxes, eTables, eFigure:
protocolized weaning for reducing the duration of mechanical ventilation in critically ill adult patients. Cochrane Database Syst Rev 2014; 11 CrossRef
Dr. med. Falk Fichtner, PD. Dr. med. Sven Laudi
Center for Anesthesiology, Emergency and Intensive Care Medicine, University of Göttingen:
Prof. Dr. med. Onnen Moerer
Department of Anesthesiology and Operative Intensive Care Medicin, Charité–Universitätsklinikum Berlin:
Prof. Dr. med. Steffen Weber-Carstens
AWMF-Institute for Medical Knowledge Management (AWMF-IMWi), AWMF office Berlin:
Dr. med. Monika Nothacker
Board of directors, Ulm University Hospital: Prof.
Dr. med. Udo Kaisers
*All editors, authors, and collaborators of the guideline are listed in the eBox.
|1.||Raymondos K, Dirks T, Quintel M, et al.: Outcome of acute respiratory distress syndrome in university and non-university hospitals in Germany. Crit Care 2017; 21: 122 CrossRef MEDLINE PubMed Central|
|2.||Bellani G, Laffey JG, Pham T, et al.: Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 2016; 315: 788–800 CrossRef MEDLINE|
|3.||Karagiannidis C, Brodie D, Strassmann S, et al.: Extracorporeal membrane oxygenation: evolving epidemiology and mortality. Intensive Care Med 2016; 42: 889–96 CrossRef MEDLINE|
|4.||Langer G, Meerpohl JJ, Perleth M, Gartlehner G, Kaminski-Hartenthaler A, Schünemann H: GRADE-Leitlinien: 1. Einführung – GRADE-Evidenzprofile und Summary-of-Findings-Tabellen. Z Evid Fortbild Qual Gesundhwes 2012; 106: 357–68 CrossRef MEDLINE|
|5.||Schünemann H: Integrative assessment of evidence in healthcare: the GRADE system. Z Evid Fortbild Qual Gesundhwes 2009; 103: 261–8 CrossRef MEDLINE|
|6.||Kaminski-Hartenthaler A, Meerpohl JJ, Gartlehner G, et al.: GRADE Leitlinien: 14. Von der Evidenz zur Empfehlung: Die Bedeutung und Darstellung von Empfehlungen. Z Evid Fortbild Qual Gesundhwes 2014; 108: 413–20 CrossRef MEDLINE|
|7.||Ranieri VM, Rubenfeld GD, Thompson BT, et al.: Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012; 307: 2526–33 MEDLINE|
|8.||Deutsche Gesellschaft für Palliativmedizin: S3-Leitlinie Palliativmedizin. www.awmf.org/uploads/tx_szleitlinien/128–001OLl_S3_Palliativmedizin_2015–07.pdf (last accessed on 6 January 2018).|
|9.||Shehabi Y, Bellomo R, Reade MC, et al.: Early intensive care sedation predicts long-term mortality in ventilated critically ill patients. Am J Respir Crit Care Med 2012; 186: 724–31 CrossRef MEDLINE|
|10.||Baron R, Binder A, Biniek R, et al.: Evidence and consensus based guideline for the management of delirium, analgesia, and sedation in intensive care medicine. Revision 2015 (DAS-Guideline 2015) – short version. Ger Med Sci 2015; 13:Doc1 MEDLINE PubMed Central|
|11.||Papazian L, Forel JM, Gacouin A, et al.: Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010; 363: 1107–16 CrossRef MEDLINE|
|12.||Sud S, Sud M, Friedrich JO, et al.: High-frequency oscillatory ventilation versus conventional ventilation for acute respiratory distress syndrome. Cochrane Database Syst Rev 2016; 4: CD004085 CrossRef|
|13.||Ferguson ND, Cook DJ, Guyatt GH, et al.: High-frequency oscillation in early acute respiratory distress syndrome. N Engl J Med 2013; 368: 795–805 CrossRef MEDLINE|
|14.||Santa Cruz R, Rojas JI, Nervi R, Heredia R, Ciapponi A: High versus low positive end-expiratory pressure (PEEP) levels for mechanically ventilated adult patients with acute lung injury and acute respiratory distress syndrome. Cochrane Database Syst Rev 2013; 6: CD009098 CrossRef|
|15.||Briel M, Meade M, Mercat A, et al.: Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA 2010; 303: 865–73 CrossRef MEDLINE|
|16.||Damiani E, Adrario E, Girardis M, et al.: Arterial hyperoxia and mortality in critically ill patients: a systematic review and meta-analysis. Crit Care 2014; 18: 711 CrossRef MEDLINE PubMed Central|
|17.||Panwar R, Hardie M, Bellomo R, et al.: Conservative versus liberal oxygenation targets for mechanically ventilated patients. A pilot multicenter randomized controlled trial. Am J Respir Crit Care Med 2016; 193: 43–51 CrossRef MEDLINE|
|18.||Putensen C, Theuerkauf N, Zinserling J, Wrigge H, Pelosi P: Meta-analysis: ventilation strategies and outcomes of the acute respiratory distress syndrome and acute lung injury. Ann Intern Med 2009; 151: 566–76 CrossRef|
|19.||Petrucci N, de Feo C: Lung protective ventilation strategy for the acute respiratory distress syndrome. Cochrane database of systematic reviews. Syst Rev 2013; 2: CD003844.|
|20.||Serpa Neto A, Hemmes SNT, Barbas CS, et al.: Protective versus conventional ventilation for surgery: a systematic review and individual patient data meta-analysis. Anesthesiol 2015; 123: 66–78 CrossRef MEDLINE|
|21.||Bein T, Bischoff M, Bruckner U, et al.: Kurzversion S2e-Leitlinie – „Lagerungstherapie und Frühmobilisation zur Prophylaxe oder Therapie von pulmonalen Funktionsstorungen“. Der Anaesthesist 2015; 64: 596–611 CrossRef MEDLINE|
|22.||Prävention der nosokomialen beatmungsassoziierten Pneumonie. Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO) beim Robert Koch-Institut. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2013; 56: 1578–90 CrossRef MEDLINE|
|23.||Barbas CSV, Ísola AM, Farias, AM, et al.: Brazilian recommendations of mechanical ventilation 2013. Part I. Rev Bras Ter Intensiva 2014; 26 CrossRef CrossRef|
|24.||Schönhofer B, Geiseler J, Dellweg D, et al.: Prolongiertes Weaning: S2k-Leitlinie herausgegeben von der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. Pneumologie 2014; 68: 19–75.|
|25.||Davidson AC, Banham S, Elliott M, et al.: BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults. Thorax 2016; 71(Suppl 2): ii1–ii35 CrossRef CrossRef|
|26.||Hosokawa K, Nishimura M, Egi M, Vincent JL: Timing of tracheotomy in ICU patients: a systematic review of randomized controlled trials. Crit Care 2015; 19: 424 CrossRef MEDLINE PubMed Central|
|27.||Siempos II, Ntaidou TK, Filippidis FT, Choi AMK: Effect of early versus late or no tracheostomy on mortality and pneumonia of critically ill patients receiving mechanical ventilation: a systematic review and meta-analysis. Lancet Respir Med 2015; 3: 150–8 CrossRef|
|28.||Suzumura EA, Figueiro M, Normilio-Silva K, et al.: Effects of alveolar recruitment maneuvers on clinical outcomes in patients with acute respiratory distress syndrome: a systematic review and meta-analysis. Intensive Care Med 2014; 40: 1227–40 CrossRef MEDLINE|
|29.||Rhodes A, Evans LE, Alhazzani W, et al.: Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 2017; 43: 304–77 CrossRef MEDLINE|
|30.||Bloomfield R, Noble DW, Sudlow A: Prone position for acute respiratory failure in adults. Cochrane Database Syst Rev 2015; 11: CD008095 CrossRef|
|31.||Adhikari NK, Dellinger RP, Lundin S, et al.: Inhaled nitric oxide does not reduce mortality in patients with acute respiratory distress syndrome regardless of severity: systematic review and meta-analysis. Crit Care 2014; 42: 404–12 CrossRef MEDLINE|
|32.||Ruan SY, Huang TM, Wu HY, Wu HD, Yu CJ, Lai MS: Inhaled nitric oxide therapy and risk of renal dysfunction: a systematic review and meta-analysis of randomized trials. Crit Care 2015; 19: 137 CrossRef MEDLINE PubMed Central|
|33.||Fitzgerald M, Millar J, Blackwood B, et al.: Extracorporeal carbon dioxide removal for patients with acute respiratory failure secondary to the acute respiratory distress syndrome: a systematic review. Crit Care Med 2014; 18: 222 CrossRef|
|34.||Sklar MC, Beloncle F, Katsios CM, Brochard L, Friedrich JO: Extracorporeal carbon dioxide removal in patients with chronic obstructive pulmonary disease: a systematic review. Intensive Care Med 2015; 41: 1752–62 CrossRef MEDLINE|
|35.||Blackwood B, Burns KE, Cardwell CR, O‘Halloran P: Protocolized versus non-|
protocolized weaning for reducing the duration of mechanical ventilation in critically ill adult patients. Cochrane Database Syst Rev 2014; 11 CrossRef
|36.||Girardis M, Busani S, Damiani E, et al.: Effect of conservative vs conventional oxygen therapy on mortality among patients in an intensive care unit: the Oxygen-ICU Randomized Clinical Trial. JAMA 2016; 316: 1583–9 CrossRef MEDLINE|
|37.||Cavalcanti AB, Suzumura ÉA, Laranjeira LN, et al.: Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs low PEEP on mortality in patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA 2017; 318: 1335–45 CrossRef MEDLINE PubMed Central|
|38.||Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342: 1301–8 CrossRef MEDLINE|
|39.||Combes A, Hajage D, Capellier G, et al.: Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med 2018; 378: 1965–75 CrossRef MEDLINE|
Der Gastroenterologe, 202010.1007/s11377-020-00478-z
Deutsches Aerzteblatt Online, 201910.3238/arztebl.2019.0286a
Contraindications to the Initiation of Veno-Venous ECMO for Severe Acute Respiratory Failure in Adults: A Systematic Review and Practical Approach Based on the Current LiteratureMembranes, 202110.3390/membranes11080584
Medizinische Klinik - Intensivmedizin und Notfallmedizin, 201910.1007/s00063-019-0533-3
Deutsches Aerzteblatt Online, 201910.3238/arztebl.2019.0286b
Platelet Function Disturbance During Veno-Venous ECMO in ARDS Patients Assessed by Multiple Electrode Aggregometry—A Prospective, Observational Cohort StudyJournal of Clinical Medicine, 201910.3390/jcm8071056
Factor XIII Activity Might Already Be Impaired before Veno-Venous ECMO in ARDS Patients: A Prospective, Observational Single-Center Cohort StudyJournal of Clinical Medicine, 202110.3390/jcm10061203
Verwendung differenzierter Beatmungsstrategien in der präklinischen Notfallmedizin in der Bundesrepublik DeutschlandDer Notarzt, 202110.1055/a-1499-6166
Deutsches Aerzteblatt Online, 202010.3238/arztebl.2020.0528
Der Internist, 202010.1007/s00108-020-00850-9